Severe acute respiratory syndrome coronavirus 2 may inflict a post‐viral condition known as
post‐COVID‐19 syndrome (PCS) or long‐COVID. Studies measuring levels of inflammatory …

Abstract Objective Post-COVID syndrome (PCS) is a poorly known entity. An underlying
chronic, low-grade inflammation (LGI) has been theorized as a pathophysiological …

Objective To evaluate differences in thromboinflammatory biomarkers between patients with
severe coronavirus disease 2019 (COVID-19) infection/death and mild infection. Patients …

Objectives Studies reported associations of inflammatory markers with the severity of COVID-
19, but conclusions were inconsistent. We aimed to provide an overview of the association …

The COVID-19 pandemic has infected millions worldwide, leaving a global burden for long-
term care of COVID-19 survivors. It is thus imperative to study post-COVID (ie, short-term) …

Summary Background At least 5–10% of subjects surviving COVID-19 develop the post-
COVID-19 condition (PCC) or" Long COVID". The clinical presentation of PCC is …

Immunity with SARS-CoV-2 infection during the acute phase is not sufficiently well
understood to differentiate mild from severe cases and identify prognostic markers. We …

Summary Coronavirus disease 2019 (COVID‐19) is a clinical syndrome caused by the
severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) virus. Patients can be …

Background To determine the utility of admission laboratory markers in the assessment and
prognostication of coronavirus disease‐2019 (COVID‐19), a systematic review and meta …

Background To systematically review clinical and biochemical characteristics associated
with the severity of the novel severe acute respiratory syndrome coronavirus 2 (SARS‐CoV …